Phytosterols: Potential Metabolic Modulators in Neurodegenerative Diseases
Niti Sharma1, Mario A Tan2, Seong Soo A An1
1Bionano Research Institute, Gachon University, 1342 Seongnam-daero, Sujeong-gu, Seongnam-si 461-701, Gyeonggi-do, Korea.
Phytosterols, like stigmasterol and beta-sitosterol, show promise for treating neurodegenerative diseases. This review highlights their diverse biological activities and therapeutic potential in neurological conditions.
Area of Science:
- Biochemistry
- Pharmacology
- Neuroscience
Background:
- Phytosterols are natural compounds found in the diet with diverse applications.
- Over 200 types of phytosterols exist, exhibiting various biological activities.
- Stigmasterol and beta-sitosterol are common phytosterols with noted neuroprotective properties.
Purpose of the Study:
- To review existing research on phytosterols concerning neurodegenerative diseases.
- To cover major phytosterols based on biosynthetic pathways.
- To highlight phytosterols with significant in vitro and in vivo biological activities.
Main Methods:
- Literature review of studies on phytosterols and neurodegenerative diseases.
- Focus on biosynthetic considerations for phytosterol selection.
- Inclusion of phytosterols with demonstrated in vitro and in vivo efficacy.
Main Results:
- Phytosterols, particularly stigmasterol and beta-sitosterol, possess biological activities relevant to neurodegenerative diseases.
- A wide range of phytosterols exhibit significant pharmacological effects.
- Selected phytosterols demonstrate potential therapeutic benefits in preclinical models.
Conclusions:
- Phytosterols represent a promising class of compounds for neurodegenerative disease research.
- Further investigation into the mechanisms and applications of phytosterols is warranted.
- Dietary phytosterols may offer a natural approach to supporting brain health.
More Related Videos
11:06Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
Published on: April 7, 2023
07:03Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
Related Concept Videos
Drugs Affecting Neurotransmitter Synthesis
Alzheimer's Disease: Treatment
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Neural Regulation
Parkinson's Disease: Overview
Pharmacodynamics in Geriatric Patients: Effects of Age
